These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 23690967

  • 1. SKP2 high expression, KIT exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumors.
    Lv A, Li Z, Tian X, Guan X, Zhao M, Dong B, Hao C.
    PLoS One; 2013; 8(5):e62951. PubMed ID: 23690967
    [Abstract] [Full Text] [Related]

  • 2. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G, Kristiansson E, Nerman O, Kindblom LG, Ahlman H, Nilsson B, Nilsson O.
    Int J Cancer; 2011 Sep 01; 129(5):1149-61. PubMed ID: 21064103
    [Abstract] [Full Text] [Related]

  • 3. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
    Shen YY, Ma XL, Wang M, Zhuang C, Ni B, Tu L, Liu Q, Zhao WY, Cao H.
    Cancer Med; 2020 Sep 01; 9(18):6485-6496. PubMed ID: 32697050
    [Abstract] [Full Text] [Related]

  • 4. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
    Li JX, Sun L, Zhao S, Shao B, Guo YH, Chen S, Liang H, Sun Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr 25; 26(4):346-356. PubMed ID: 37072312
    [Abstract] [Full Text] [Related]

  • 5. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C, Lee EJ, Kim M, Lim HY, Choi DI, Noh JH, Sohn TS, Kim S, Kim MJ, Lee HK, Kim KM.
    Ann Surg; 2008 Jun 25; 247(6):1011-8. PubMed ID: 18520229
    [Abstract] [Full Text] [Related]

  • 6. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with KIT/PDGFRA gene "homozygous mutation": a multicenter retrospective cohort study].
    Shen YY, Li XQ, Yang LX, Fang Y, Nie MM, He ZR, Hou YY, Cao H, Wang M, Shen KT.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep 25; 24(9):804-813. PubMed ID: 34530562
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
    Wang H, Chen P, Liu XX, Zhao W, Shi L, Gu XW, Zhu CR, Zhu HH, Zong L.
    World J Surg Oncol; 2014 Apr 09; 12():89. PubMed ID: 24712384
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor.
    Quek R, Farid M, Kanjanapan Y, Lim C, Tan IB, Kesavan S, Lim TKH, Oon LL, Goh BK, Chan WH, Teo M, Chung AY, Ong HS, Wong WK, Tan P, Yip D.
    Asia Pac J Clin Oncol; 2017 Jun 09; 13(3):115-124. PubMed ID: 27753268
    [Abstract] [Full Text] [Related]

  • 9. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J, Maurel J, Calabuig S, Gutierrez A, González de Sande JL, Martínez J, De Juan A, Laínez N, Losa F, Alija V, Escudero P, Casado A, García P, Blanco R, Buesa JM, Spanish Group for Sarcoma Research.
    J Clin Oncol; 2005 Sep 01; 23(25):6190-8. PubMed ID: 16135486
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
    Koay MH, Goh YW, Iacopetta B, Grieu F, Segal A, Sterrett GF, Platten M, Spagnolo DV.
    Pathology; 2005 Feb 01; 37(1):22-31. PubMed ID: 15875730
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.
    Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, Fletcher JA.
    J Clin Oncol; 2002 Sep 15; 20(18):3898-905. PubMed ID: 12228211
    [Abstract] [Full Text] [Related]

  • 13. Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.
    Hou YY, Grabellus F, Weber F, Zhou Y, Tan YS, Li J, Shen KT, Qin J, Sun YH, Qin XY, Bockhorn M, Gerken G, Broelsch CE, Frilling A.
    J Gastrointest Surg; 2009 Sep 15; 13(9):1583-92. PubMed ID: 19291337
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
    Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T.
    Gastric Cancer; 2003 Sep 15; 6(1):39-48. PubMed ID: 12673425
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis.
    Yan L, Zou L, Zhao W, Wang Y, Liu B, Yao H, Yu H.
    Sci Rep; 2015 Sep 09; 5():13718. PubMed ID: 26349547
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M, Lasota J.
    Arch Pathol Lab Med; 2006 Oct 09; 130(10):1466-78. PubMed ID: 17090188
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, Jang KS, Paik SS, Oh YH, Chae SW, Sohn JH, Kim HJ, Cho YK, Kim BI, Park DI, Sohn CI, Oh S, Choi SH, Choi YJ, Woo HY, Park YL, Park SJ, Lee SH, Ryu S, DO SI, Kang G, Kim K, Cho YH, Pyo JS.
    Anticancer Res; 2012 Mar 09; 32(3):923-37. PubMed ID: 22399613
    [Abstract] [Full Text] [Related]

  • 18. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J, Bümming P, Meis-Kindblom JM, Sihto H, Nupponen N, Joensuu H, Odén A, Gustavsson B, Kindblom LG, Nilsson B.
    Gastroenterology; 2006 May 09; 130(6):1573-81. PubMed ID: 16697720
    [Abstract] [Full Text] [Related]

  • 19. [Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].
    Sun XF, Gao XD, Yuan W, Sun JY, Fu M, Xue AW, Li H, Shu P, Fang Y, Hou YY, Shen KT, Sun YH, Qin J, Qin XY.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep 25; 23(9):880-887. PubMed ID: 32927513
    [Abstract] [Full Text] [Related]

  • 20. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y.
    Am J Surg Pathol; 2011 Sep 25; 35(9):1287-95. PubMed ID: 21836495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.